F2 and pertussis: Although treatment of children suffering from pertussis with P-IGIV produced inconclusive effects on cough [44,114], the recently developed humanized monoclonal antibodies to PT show beneficial effects in B. pertussis-infected experimental mice and baboons [45] and warrant further investigation.